Related Experiment Video
Updated: Jun 25, 2026
07:07
Tumor Hypoxia Assessment: In Vivo 3D Oxygen Imaging Through Electron Paramagnetic Resonance
Published on: February 14, 2025
Immunohistochemical detection of changes in tumor hypoxia
James Russell1, Sean Carlin, Sean A Burke
1Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA. russellj@mskcc.org
Summary
Hypoxia markers like EF5 and HIF1alpha can detect tumor reoxygenation. This technique using exogenous and endogenous markers may be applicable to patient samples.
Area of Science:
- Oncology
- Biomedical Engineering
- Cancer Research
Background:
- Hypoxia is a critical prognostic factor in cancer.
- The rate of reoxygenation significantly modifies the effects of tumor hypoxia.
- Accurate detection of reoxygenation is essential for understanding tumor behavior and treatment response.
Purpose of the Study:
- To evaluate exogenous and endogenous markers for detecting tumor reoxygenation.
- To assess the utility of pimonidazole, EF5, carbonic anhydrase IX (CAIX), and hypoxia-inducible factor 1alpha (HIF1alpha) in a xenograft model.
- To determine if these markers can be applied to stored patient samples.
Main Methods:
- Human colorectal carcinoma cells (HT29) were grown in nude mice.
- Tumor hypoxia was assessed using pimonidazole and EF5 injections.
- Markers including CAIX and HIF1alpha were stained in cryosections.
- Tumor hypoxia was modulated using carbogen exposure.
Main Results:
- Pimonidazole and EF5 effectively detected decreased hypoxia after carbogen treatment.
- HIF1alpha staining decreased relative to CAIX, indicating reoxygenation.
- Spatial distributions of all four markers were similar in unstressed tumors.
- Spontaneous changes in tumor hypoxia were reflected by CAIX and HIF1alpha.
Conclusions:
- HIF1alpha can be used with CAIX or a nitroimidazole to estimate tumor reoxygenation.
- Exogenous markers like EF5 provide sensitive detection of reoxygenation.
- The findings suggest potential application for analyzing stored patient tumor samples.
Related Concept Videos
01:23Hypoxia
Hypoxia is a medical condition characterized by an inadequate oxygen supply to body tissues. It typically manifests as a bluish discoloration of the skin and mucosae, especially in fair-skinned individuals, when hemoglobin (Hb) saturation drops below 75%.
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
Types of Hypoxia
There are four primary types of hypoxia, each resulting from a different cause:
1. Anemic hypoxia: This type occurs due to insufficient oxygen delivery caused by a lack of red blood cells (RBCs) or RBCs with abnormal or...
02:53Adaptive Mechanisms in Cancer Cells
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
01:24Regulation of Angiogenesis and Blood Supply
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl hydroxylase and factor...